Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-27T03:43:28.779Z Has data issue: false hasContentIssue false
  • English
  • Français

The Value of GRE, ADC and Routine MRI in Distinguishing Parkinsonian Disorders

Published online by Cambridge University Press:  23 September 2014

Pettarusp M. Wadia ,
Peter Howard ,
Manuel Q. Ribeirro ,
Jennifer Robblee ,
Abena Asante ,
David J. Mikulis  and
Anthony E. Lang
Pettarusp M. Wadia
Affiliation:
Movement Disorders Center and the Edmond J. Safra Program in Parkinson's Disease, Division of Neurology, University Health Network, University of Toronto, Canada Department of Neurology, Jaslok Hospital and Research Institute, Mumbai, India
Peter Howard
Affiliation:
Department of Medical Imaging, Toronto Western Hospital, University Health Network, University of Toronto, Canada
Manuel Q. Ribeirro
Affiliation:
Department of Medical Imaging, Toronto Western Hospital, University Health Network, University of Toronto, Canada
Jennifer Robblee
Affiliation:
Movement Disorders Center and the Edmond J. Safra Program in Parkinson's Disease, Division of Neurology, University Health Network, University of Toronto, Canada
Abena Asante
Affiliation:
Movement Disorders Center and the Edmond J. Safra Program in Parkinson's Disease, Division of Neurology, University Health Network, University of Toronto, Canada
David J. Mikulis
Affiliation:
Department of Medical Imaging, Toronto Western Hospital, University Health Network, University of Toronto, Canada
Anthony E. Lang*
Affiliation:
Movement Disorders Center and the Edmond J. Safra Program in Parkinson's Disease, Division of Neurology, University Health Network, University of Toronto, Canada
*
399 bathurst Street, MC-7-402, Toronto Western Hospital, Toronto, ontario, M5T 2S8, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objectives:

To study different radiological signs and sequences including apparent diffusion coefficient (ADC) and gradient echo (GRE) to differentiate degenerative parkinsonian syndromes.

Background:

Multiple system atrophy (MSA), Parkinson's disease (PD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CbD) differ in the pattern of neurodegeneration and cellular damage. Measuring the ADC, GRE sequences for paramagnetic substances and simple anatomical assessments have been reported individually to assist in separating some of these disorders, but have not been compared.

Methods:

brain MRIs from May 2002 to February 2008 were retrospectively evaluated by raters blinded to the clinical diagnosis for predefined MRI signs on T1, T2 and GRE sequences. ADC values were quantitatively measured. Medical records were objectively analyzed using standard clinical criteria for different parkinsonian syndromes.

Results:

195 cases comprising of 61 PD, 15 MSA-P, 7 MSA-C, 21 PSP, 6 Corticobasal syndrome, 21 not fitting criteria and 64 controls were evaluated. 73% of patients with MSA-P had hypointensity of the putamen (compared to the pallidum) on GRE. The specificity of this sign to diagnose MSA-P was 90% versus PD and 76% versus PSP. When GRE hypointensity was combined with atrophy of the putamen the specificity improved to 98% (versus PD) and 95% (versus PSP) without altering the sensitivity. The ADC values were significantly higher in the middle cerebellar peduncle in cases with MSA-C versus controls, PD and PSP (p<0.001).

Conclusions:

The combination of hypointensity and atrophy of the putamen on GRE is useful in differentiating MSA-P from other parkinsonian syndromes.

Résumé:

Résumé:Objectif:

Le but de l'étude était d'examiner les différents signes et les différentes séquences radiologiques, dont le coefficient de diffusion apparent (CDA) et échos de gradient (ÉG) pour différencier les syndromes parkinsoniens dégénératifs.

Contexte:

Les caractéristiques de neurodégénérescence et de dommage cellulaire sont différentes dans l'atrophie multisystémique (AMS), la maladie de Parkinson (MP), la paralysie supranucléaire progressive (PSP) et la dégénérescence cortico-basale (DCb). Des mesures du CDA, des séquences ÉG des substances paramagnétiques ainsi que des évaluations anatomiques simples ont été rapportées séparément pour aider à distinguer certaines de ces maladies, mais elles n'ont jamais été comparées entre elles.

Méthode:

Des évaluateurs ont revu rétrospectivement les IRM du cerveau effectuées entre mai 2002 et février 2008, sans connaître le diagnostic clinique posé chez les patients, afin d'identifier des signes prédéfinis à l'IRM en T1, en T2 et dans les séquences ÉG. Les valeurs du CDA ont été mesurées quantitativement. Les dossiers médicaux ont été analysés objectivement au moyen des critères cliniques standards des différents syndromes parkinsoniens.

Résultats:

Cent quatre-vingt-quinze cas dont 61 cas de MP, 15 cas d'AMS-P, 7 cas d'AMS-C, 21 cas de PSP, 6 cas de syndrome cortico-basal, 21 cas qui ne rencontraient pas les critères standards et 64 témoins ont été évalués. Soixante-treize pour cent des patients atteints d'AMS-P avaient de l'hypointensité au niveau du putamen par rapport au pallidum à l'ÉG. La spécificité de ce signe pour le diagnostic de l'AMS-P était de 90% par rapport à la MP et de 76% par rapport à la PSP. Quand l'hypointensité à l'ÉG était combinée à l'atrophie du putamen, la spécificité s'élevait à 98% par rapport à la MP et à 95% par rapport à la PSP, sans en modifier la sensibilité. Les valeurs du CDA étaient significativement plus élevées dans le pédoncule cérébelleux chez les cas d'AMS-C par rapport aux témoins et par rapport aux patients atteints de MP et de PSP (p < 0,001).

Conclusion:

La combinaison d'hypointensité et d’atrophie du putamen à l'ÉG est utile pour différencier l'AMS-P des autres syndromes parkinsoniens.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 40 , Issue 3 , May 2013 , pp. 389 - 402
Copyright
Copyright © The Canadian Journal of Neurological 2013

References

1. Hauw, JJ, Daniel, SE, Dickson, D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-olszewski syndrome (progressive supranuclear palsy). Neurology. 1994;44:2015–19.CrossRefGoogle ScholarPubMed
2. Wenning, GK, Tison, F, Elliott, L, Quinn, NP, Daniel, SE. olivopontocerebellar pathology in multiple system atrophy. Mov Disord. 1996;11:157–62.CrossRefGoogle ScholarPubMed
3. Braak, H, Del Tredici, K, Rub, U, de Vos, RA, Jansen Steur, EN, Braak, E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24:197–211.CrossRefGoogle ScholarPubMed
4. Oba, H, Yagishita, A, Terada, H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology. 2005;64:2050–5.CrossRefGoogle ScholarPubMed
5. Paviour, DC, Price, SL, Stevens, JM, Lees, AJ, Fox, NC. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology. 2005;64:675–9.CrossRefGoogle ScholarPubMed
6. Paviour, DC, Price, SL, Jahanshahi, M, Lees, AJ, Fox, NC. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain. 2006;129:1040–9.CrossRefGoogle ScholarPubMed
7. Schulz, JB, Skalej, M, Wedekind, D, et al. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol. 1999;45:65–74.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
8. Adachi, M, Kawanami, T, Ohshima, H, Sugai, Y, Hosoya, T. Morning glory sign: a particular MR finding in progressive supranuclear palsy. Magn Reson Med Sci. 2004;3:125–32.CrossRefGoogle ScholarPubMed
9. Ito, S, Shirai, W, Hattori, T. Evaluating posterolateral linearization of the putaminal margin with magnetic resonance imaging to diagnose the Parkinson variant of multiple system atrophy. Mov Disord. 2007;22:578–81.CrossRefGoogle ScholarPubMed
10. Kraft, E, Schwarz, J, Trenkwalder, C, Vogl, T, Pfluger, T, Oertel, WH. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol. 1999;56:225–8.CrossRefGoogle ScholarPubMed
11. Yekhlef, F, Ballan, G, Macia, F, Delmer, O, Sourgen, C, Tison, F. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. J Neural Transm. 2003;110:151–69.CrossRefGoogle ScholarPubMed
12. Rolland, Y, Verin, M, Payan, CA, et al. A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability. J Neurol Neurosurg Psychiatry. 2011;82:1025–32.CrossRefGoogle ScholarPubMed
13. Kraft, E, Trenkwalder, C, Auer, DP. *-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology. 2002;59:1265–7.CrossRefGoogle ScholarPubMed
14. von Lewinski, F, Werner, C, Jorn, T, Mohr, A, Sixel-Doring, F, Trenkwalder, C. T2(*)-weighted MRI in diagnosis of multiple system atrophy: a practical approach for clinicians. J Neurol. 2007;254:1184–8.CrossRefGoogle ScholarPubMed
15. Blain, CR, Barker, GJ, Jarosz, JM, et al. Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology. 2006;67:2199–205.CrossRefGoogle ScholarPubMed
16. Nicoletti, G, Lodi, R, Condino, F, et al. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain. 2006;129:2679–87.CrossRefGoogle ScholarPubMed
17. Paviour, DC, Thornton, JS, Lees, AJ, Jager, HR. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy. Mov Disord. 2007;22:68–74.CrossRefGoogle ScholarPubMed
18. Schocke, MF, Seppi, K, Esterhammer, R, et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology. 2002;58:575–80.CrossRefGoogle ScholarPubMed
19. Schocke, MF, Seppi, K, Esterhammer, R, et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage. 2004;21:1443–51.CrossRefGoogle ScholarPubMed
20. Seppi, K, Schocke, MF, Donnemiller, E, et al. Comparison of diffusion-weighted imaging and [123I]IbZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease. Mov Disord. 2004;19:1438–45.CrossRefGoogle ScholarPubMed
21. Seppi, K, Schocke, MF, Mair, KJ, et al. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage. 2006;31:240–5.CrossRefGoogle ScholarPubMed
22. Le Bihan, D, Turner, R, Douek, P, Patronas, N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol. 1992;159:591–9.CrossRefGoogle ScholarPubMed
23. Seppi, K, Schocke, MF, Esterhammer, R, et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology. 2003;60:922–7.CrossRefGoogle Scholar
24. Brass, S, Chen, N, Mukern, R, Bakshi, R. Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Resonance Imaging. 2006;17:31–40.CrossRefGoogle ScholarPubMed
25. Lang, A, Curran, T, Bergeron, C. Striatonigral degeneration: iron deposition in putamen correlates with the slit-like void signal of magnetic resonance imaging. Can J Neurol Sci. 1994;9:311–18.CrossRefGoogle Scholar
26. Matsusue, E, Fujii, S, Kanasaki, Y, et al. Putaminal lesion in multiple system atrophy: postmortem MR-pathological correlations. Neuroradiology. 2008;50:559–67.CrossRefGoogle ScholarPubMed
27. Boeve, BF, Lang, AE, Litvan, I. Corticobasal degeneration and its relationship to progressive supranulear palsy and frontotemporal dementia. Ann Neurol. 2003;54:S15–19.CrossRefGoogle Scholar
28. Litvan, I, Agid, Y, Calne, D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47:1–9.CrossRefGoogle ScholarPubMed
29. Litvan, I, Bhatia, KP, Burn, DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord. 2003;18:467–86.CrossRefGoogle ScholarPubMed
30. Gilman, S, Low, PA, Quinn, N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163:94–8.CrossRefGoogle ScholarPubMed
31. Hughes, A, Daniel, S, Kilford, L, Lees, AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–4.CrossRefGoogle ScholarPubMed
32. Righini, A, Antonini, A, Ferrarini, M, et al. Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. J Comput Assist Tomogr. 2002;26:266–71.CrossRefGoogle ScholarPubMed
33. Bhattacharya, K, Saadia, D, Eisenkraft, B, et al. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol. 2002;59:835–42.CrossRefGoogle ScholarPubMed
34. Kato, T, Kume, A, Ito, K, Tadokoro, M, Takahashi, A, Sakuma, S. Asymmetrical FDG-PET and MRI findings of striatonigral system in multiple system atrophy with hemiparkinsonism. Radiat Med. 1992;10:87–93.Google ScholarPubMed
35. Warmuth-Metz, M, Naumann, M, Csoti, I, Solymosi, L. Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol. 2001;58:1076–9.CrossRefGoogle ScholarPubMed
36. Landis, J, Koch, G. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.CrossRefGoogle ScholarPubMed
37. Drayer, BP, Olanow, W, Burger, P, Johnson, GA, Herfkens, R, Riederer, S. Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology. 1986;159:493–8.CrossRefGoogle Scholar
38. Naka, H, Imon, Y, Ohshita, T, et al. Magnetization transfer measurements of brain structures in patients with multiple system atrophy. Neuroimage. 2002;17:1572–8.CrossRefGoogle ScholarPubMed
39. Nicoletti, G, Fera, F, Condino, F, et al. MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. Radiology. 2006;239:825–30.CrossRefGoogle ScholarPubMed
40. Pastakia, B, Polinsky, R, Di Chiro, G, Simmons, JT, Brown, R, Wener, L. Multiple system atrophy (Shy-Drager syndrome): MR imaging. Radiology. 1986;159:499–502.CrossRefGoogle ScholarPubMed
41. Righini, A, Antonini, A, De Notaris, R, et al. MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol. 2004;25:927–32.Google ScholarPubMed
42. Lee, JY, Yun, JY, Shin, CW, Kim, HJ, Jeon, BS. Putaminal abnormality on 3-T magnetic resonance imaging in early parkinsonism-predominant multiple system atrophy. J Neurol. 2010;257:2065–70.CrossRefGoogle ScholarPubMed
43. Ito, M, Watanabe, H, Kawai, Y, et al. Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy. J Neurol Neurosurg Psychiatry. 2007;78:722–8.CrossRefGoogle ScholarPubMed
44. Schrag, A, Good, CD, Miszkiel, K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology. 2000;54:697–702.CrossRefGoogle ScholarPubMed
45. Lee, WH, Lee, CC, Shyu, WC, Chong, PN, Lin, SZ. Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T. AJNR Am J Neuroradiol. 2005;26:2238–42.Google Scholar
46. Watanabe, H, Ito, M, Fukatsu, H, et al. Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophy. Mov Disord. 2010;25:1916–23.CrossRefGoogle ScholarPubMed
47. Watanabe, H, Saito, Y, Terao, S, et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain. 2002;125:1070–83.CrossRefGoogle ScholarPubMed
48. Shrivastava, A. The hot cross bun sign. Radiology. 2007;245:606–7.CrossRefGoogle ScholarPubMed
49. Takao, M, Taro, K, Tomita, Y, Yoshida, Y, Mihara, B. ‘Hot-cross bun sign’ of multiple system atrophy. Intern Med. 2007;46:1883.CrossRefGoogle ScholarPubMed
50. Burk, K, Skalej, M, Dichgans, J. Pontine MRI hyperintensities (“the cross sign”) are not pathognomonic for multiple system atrophy (MSA). Mov Disord. 2001;16:535.CrossRefGoogle Scholar
51. Murata, Y, Yamaguchi, S, Kawakami, H, et al. Characteristic magnetic resonance imaging findings in Machado-Joseph disease. Arch Neurol. 1998;55:33–7.CrossRefGoogle ScholarPubMed
52. Ngai, S, Tang, YM, Du, L, Stuckey, S. Hyperintensity of the middle cerebellar peduncles on fluid-attenuated inversion recovery imaging: variation with age and implications for the diagnosis of multiple system atrophy. AJNR Am J Neuroradiol. 2006;27:2146–8.Google ScholarPubMed
53. Loesch, DZ, Cook, M, Litewka, L, et al. A low symptomatic form of neurodegeneration in younger carriers of the FMR1 premutation, manifesting typical radiological changes. J Med Genet. 2008;45:179–81.CrossRefGoogle ScholarPubMed
54. Okamoto, K, Tokiguchi, S, Furusawa, T, et al. MR features of diseases involving bilateral middle cerebellar peduncles. AJNR Am J Neuroradiol. 2003;24:1946–54.Google ScholarPubMed
55. Asato, R, Akiguchi, I, Masunaga, S, Hashimoto, N. Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy. J Neural Transm. 2000;107:1427–36.CrossRefGoogle ScholarPubMed
56. Kato, N, Arai, K, Hattori, T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci. 2003;210:57–60.CrossRefGoogle ScholarPubMed
57. Wang, Y, Butros, SR, Shuai, X, et al. Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging. AJNR Am J Neuroradiol. 2012;33:266–73.CrossRefGoogle ScholarPubMed
58. Sakurai, K, Kawaguchi, T, Kawai, T, et al. Usefulness of 3D-PRESTo imaging in evaluating putaminal abnormality in parkinsonian variant of multiple system atrophy. Neuroradiology. 2009;6:6.Google Scholar
59. Gupta, D, Saini, J, Kesavadas, C, Sarma, PS, Kishore, A. Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism. Neuroradiology. 2010:52:1087–94.CrossRefGoogle ScholarPubMed
60. Arabia, G, Morelli, M, Paglionico, S, et al. An magnetic resonance imaging T2*-weighted sequence at short echo time to detect putaminal hypointensity in Parkinsonisms. Mov Disord. 2010;25:2728–34.CrossRefGoogle ScholarPubMed
61. Pellecchia, MT, Barone, P, Mollica, C, et al. Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Mov Disord. 2009;24:689–96.CrossRefGoogle ScholarPubMed
62. Kanazawa, M, Shimohata, T, Terajima, K, et al. Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging. J Neurol. 2004;251:1121–4.CrossRefGoogle ScholarPubMed
63. Taoka, T, Kin, T, Nakagawa, H, et al. Diffusivity and diffusion anisotropy of cerebellar peduncles in cases of spinocerebellar degenerative disease. Neuroimage. 2007;37:387–93.CrossRefGoogle ScholarPubMed
64. Morelli, M, Arabia, G, Novellino, F, et al. MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study. Neurology. 2011;77:1042–7.CrossRefGoogle ScholarPubMed
65. Canu, E, Agosta, F, Baglio, F, Galantucci, S, Nemni, R, Filippi, M. Diffusion tensor magnetic resonance imaging tractography in progressive supranuclear palsy. Mov Disord. 2011;26:1752–5.CrossRefGoogle ScholarPubMed